Combinations of EGFR and MET inhibitors reduce proliferation and invasiveness of mucosal melanoma cells

Mucosal melanoma (MM) is a very rare and aggressive type of cancer for which immunotherapy or targeted therapy such as BRAF/MEK inhibitors, used in cutaneous melanoma, usually fail. Due to our earlier experience showing the high effectiveness of epidermal growth factor receptor (EGFR) and hepatocyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Simiczyjew, Aleksandra, Wądzyńska, Justyna, Kot, Magdalena, Ziętek, Marcin, Matkowski, Rafał, Hoang, Mai P., Donizy, Piotr, Nowak, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538264/
https://www.ncbi.nlm.nih.gov/pubmed/37679999
http://dx.doi.org/10.1111/jcmm.17935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538264/
https://www.ncbi.nlm.nih.gov/pubmed/37679999
http://dx.doi.org/10.1111/jcmm.17935

Ejemplares similares